Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) is an ethical protocol developed by the

World Health Organization The World Health Organization (WHO) is a list of specialized agencies of the United Nations, specialized agency of the United Nations which coordinates responses to international public health issues and emergencies. It is headquartered in Gen ...

to evaluate the potential use of experimental drugs in the event of public health emergencies. The protocol was created by the WHO Ebola Ethics Working Group in 2014 in the context of the

2014 West Africa Ebola outbreak The 2013–2016 epidemic of Ebola virus disease, centered in West Africa, was the most widespread outbreak of the disease in history. It caused major loss of life and socioeconomic disruption in the region, mainly in Guinea, Liberia and S ...

. The WHO recommends that the term be preferred to the term "

compassionate use Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life ...

" or "

expanded access Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug, investigational new drug applications (IND) or Investigational device exemption, IDE application for devices, o ...

" for the controlled use of unregistered treatments in public health emergency measures.

References

Medical ethics Clinical pharmacology Health policy Ebola {{med-stub